![Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - Annals of Oncology Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f9dfd06e-a4c1-43ca-979f-e4e7e6ff43dd/gr2_lrg.jpg)
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - Annals of Oncology
![Clinical significance of serum tumor markers CA 153 , CA 125 , CA 724 and FIB , IL-6 levels detection in ovarian cancer | Semantic Scholar Clinical significance of serum tumor markers CA 153 , CA 125 , CA 724 and FIB , IL-6 levels detection in ovarian cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e7c2628d0dd7611a103deba079da13643b40cc10/3-Table4-1.png)
Clinical significance of serum tumor markers CA 153 , CA 125 , CA 724 and FIB , IL-6 levels detection in ovarian cancer | Semantic Scholar
![The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt-2020-0015/asset/images/medium/figure1.gif)
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
![Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes - Lung Cancer Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes - Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c1ec0b06-6032-4fa7-a3a2-4026d7b9af7b/pl1_lrg.jpg)
Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes - Lung Cancer
![Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - Clinical Gastroenterology and Hepatology Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - Clinical Gastroenterology and Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5e6a3bad-025f-4e08-a863-268e17649522/gr1_lrg.jpg)
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - Clinical Gastroenterology and Hepatology
![Tumor Marker:- Part 4 - CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 - Labpedia.net Tumor Marker:- Part 4 - CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 - Labpedia.net](https://labpedia.net/wp-content/uploads/2020/01/Tumor-marker-diagnosis-prognosis-3.jpg)
Tumor Marker:- Part 4 - CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 - Labpedia.net
![The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt-2020-0015/asset/images/medium/figure2.gif)
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
![Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies](http://www.tropicalgastro.com/uploads/Untitlnkged-30.jpg)
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
![Characterization of the Oligosaccharides Associated with the Human Ovarian Tumor Marker CA125* - Journal of Biological Chemistry Characterization of the Oligosaccharides Associated with the Human Ovarian Tumor Marker CA125* - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/b477e552-f614-48c7-84d4-a1ded8c21c30/gr1.jpg)
Characterization of the Oligosaccharides Associated with the Human Ovarian Tumor Marker CA125* - Journal of Biological Chemistry
PLOS ONE: CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma
![References in Use of a Panel of Tumor Markers (Carcinoembryonic Antigen, Cancer Antigen 125, Carbohydrate Antigen 15–3, and Cytokeratin 19 Fragments) in Pleural Fluid for the Differential Diagnosis of Benign and Malignant Effusions - CHEST References in Use of a Panel of Tumor Markers (Carcinoembryonic Antigen, Cancer Antigen 125, Carbohydrate Antigen 15–3, and Cytokeratin 19 Fragments) in Pleural Fluid for the Differential Diagnosis of Benign and Malignant Effusions - CHEST](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2080315983/2071762892/gr1.jpg)